◀ Back to MYLIP
MEF2C — MYLIP
Text-mined interactions from Literome
Granjon et al., Diabetes 2009
(Diabetes Mellitus, Type 2...) :
We further demonstrated that sterol regulatory element binding protein ( SREBP)-1c and
myocyte enhancer factor 2C were
involved in the effect of insulin on miR-1 and
miR-133a expression
Lu et al., Cardiovasc Res 2010
(Diabetes Mellitus, Type 2...) :
Using in silico miRNA target prediction programs, we prioritized candidate miR-223 target genes, but observed no
effect of
miR-223 on
myocyte enhancer factor 2c or insulin-like growth factor 1 receptor, and an unexpected miR-223 induced increase in nuclear factor IA
Wilson et al., Circulation. Cardiovascular genetics 2010
:
Overexpression of miR-499 and -1 resulted in upregulation of important cardiac myosin heavy-chain genes in embryoid bodies ;
miR-499 overexpression also
caused upregulation of the cardiac transcription factor
MEF2C
Shen et al., Am J Pathol 2011
(Hypertrophy...) :
Overexpression of
miR-373 decreased the cell size, and also
reduced the level of its target gene
MEF2C , and miR-373 expression was regulated by p38
Cesana et al., Cell 2011
(Muscular Dystrophy, Duchenne) :
We show that linc-MD1 `` sponges ''
miR-133 and miR-133 [ corrected ] to
regulate the expression of MAML1 and
MEF2C , transcription factors that activate muscle-specific gene expression
Kornfeld et al., Nat Cell Biol 2012
:
Adrenergic stimulation inhibits expression of
miR-133a/b in a
Mef2c dependent manner to abrogate post-transcriptional silencing of Prdm16